News & Updates

Show Multimedia Only

Adverse events occur in two-thirds of NASH patients on placebo

24 Apr 2023

Nearly two in three participants in the placebo arm of nonalcoholic steatohepatitis (NASH) randomized clinical trials (RCTs) experience an adverse event (AE), while one in 10 have a serious AE, according to a pooled analysis of studies with NASH placebo.

24 Apr 2023

Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection

23 Apr 2023

Ten-day treatment with vonoprazan 20 mg twice/day plus amoxicillin 750 mg four times/day (VHA-dual) as a first-line therapy for Helicobacter pylori infection results in satisfactory eradication rate of >90 percent, fewer adverse events (AEs), and similar adherence when compared with bismuth quadruple therapy (B-quadruple), results of a study have shown.

23 Apr 2023

COVID-19 survivors at high risk of subsequent IBS

21 Apr 2023

Individuals who have contracted COVID-19 at increased risk of developing irritable bowel syndrome (IBS) compared with those who have not been infected, as reported in a study.

21 Apr 2023

Buspirone does little to improve gastroparesis symptoms

21 Apr 2023

Treatment with the 5-HT1 receptor agonist buspirone in patients with gastroparesis falls short of reducing symptoms including moderate-to-severe early satiety/postprandial fullness, according to a study.

21 Apr 2023

Over-the-scope clips more effective than standard treatment for nonvariceal upper GI bleeding

19 Apr 2023 by

A randomized controlled trial of 190 patients from university teaching hospitals in Hong Kong, mainland China, and Australia finds that initial treatment of nonvariceal upper gastrointestinal (GI) bleeding with over-the-scope clips (OTSCs) reduces the risk of further bleeding vs standard endoscopic haemostatic treatment.

19 Apr 2023

More movement tied to lower risks of hospitalization for common health conditions

18 Apr 2023 by

Individuals engaging in more physical activities had lower risks of hospitalization for a multitude of common health conditions, according to a prospective cohort study using data from the UK Biobank.

18 Apr 2023

Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery

15 Apr 2023

In patients with early rectal cancer (ERC), endoscopic submucosal dissection (ESD) appears safer and is associated with shorter hospital stay than transanal endoscopic microsurgery (TEM), results of a recent study have shown.

15 Apr 2023

Excessive air swallowing linked to dyspepsia, poor response to PPI therapy

14 Apr 2023

Swallowing more air appears to induce both dyspepsia and refractoriness to typical symptoms of gastroesophageal reflux disease (GERD) to proton pump inhibitor (PPI) therapy, suggests a study.

14 Apr 2023

Chemo beneficial in node-positive appendix adenocarcinoma

13 Apr 2023 by

Chemotherapy appears to confer survival advantage in patients with appendix adenocarcinoma who have node-positive tumours, according to a study presented at ESMO Sarcoma 2023.

13 Apr 2023

IBD patients at higher risk of Alzheimer’s disease

13 Apr 2023

Inflammatory bowel disease (IBD) shows an independent relationship with the development of Alzheimer’s disease (AD), with such association being stronger in patients with Crohn’s disease (CD) than those with ulcerative colitis (UC), reveals a study.

13 Apr 2023

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

Adverse events occur in two-thirds of NASH patients on placebo

Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection

COVID-19 survivors at high risk of subsequent IBS

Buspirone does little to improve gastroparesis symptoms

Over-the-scope clips more effective than standard treatment for nonvariceal upper GI bleeding

More movement tied to lower risks of hospitalization for common health conditions

Endoscopic submucosal dissection safer, more cost-effective than transanal endoscopic microsurgery

Excessive air swallowing linked to dyspepsia, poor response to PPI therapy

Chemo beneficial in node-positive appendix adenocarcinoma

IBD patients at higher risk of Alzheimer’s disease